natgillin/translations-raw huggingface dataset:
De hyppigste bivirkninger ved Betaferon er influenzalignende symptomer (herunder feber, forkølelse, ledsmerter, utilpashed, sveden, hovedpine og muskelsmerter) og reaktioner på injektionsstedet).
The most frequent side effects with Betaferon are flu-like symptoms (including fever, chills, arthralgia (joint pain), malaise (feeling unwell), sweating, headache and myalgia (muscle pain)) and reactions at the site of injection.
De hyppigste bivirkninger ved Binocrit (som optræder hos flere end 1 ud af 10 patienter) er kvalme, diarré, opkastning, feber og hovedpine.
The most common side effects with Binocrit (seen in more than 1 patient in 10) are nausea (feeling sick),diarrhoea, vomiting, pyrexia (fever) and headache.
De hyppigste bivirkninger ved Blincyto (som optræder hos mere end 1 ud af 10 patienter) er infusionsrelaterede reaktioner (såsom feber og kulderystelser), infektioner, feber (pyreksi), hovedpine, lavt antal hvide blodlegemer og feber (febril neutropeni), hævelse af især ankler og fødder (perifert ødem), kvalme, for lavt kaliumindhold i blodet (hypokaliæmi), forstoppelse, lavt antal røde blodlegemer (anæmi), hoste, diarré, rystelser (tremor), neutropeni, mavesmerter, søvnløshed, træthed og kulderystelser.
The most common side effects with Blincyto (which may affect more than 1 in 10 people) are infusion- related reactions (like fever, chills and shivering), infections, pyrexia (fever), headache, febrile neutropenia (low white blood cell counts with fever), peripheral oedema (swelling, especially of the ankles and feet), nausea (feeling sick), hypokalaemia (low blood potassium levels), constipation, anaemia (low red blood cell counts), cough, diarrhoea, tremor (shaking), neutropenia, abdominal pain, insomnia, fatigue and chills.
De hyppigste bivirkninger ved Brinavess (som optræder hos flere end 1 ud af 10 patienter) er smagsforstyrrelser (dysgeusi) og nysen.
The most common side effects with Brinavess (seen in more than 1 patient in 10) are dysgeusia (taste disturbances) and sneezing.
De hyppigste bivirkninger ved Briviact (som kan forekomme hos over 1 ud af 10 personer) er søvnighed (somnolens) og svimmelhed.
The most common side effects with Briviact (which may affect more than 1 in 10 people) are somnolence (sleepiness) and dizziness.
De hyppigste bivirkninger ved Bydureon var hovedsagelig problemer med maven og tarmene (kvalme og diarré ).
The most common side effects seen with Bydureon were mainly problems affecting the stomach and gut (nausea (feeling sick) and diarrhoea).
De hyppigste bivirkninger ved Cabometyx (set hos mindst 1 ud af 4 patienter) er diarré, træthed, kvalme, appetitløshed, hånd-fod-syndrom (der omfatter udslæt og følelsesløshed på håndflader og fodsåler), forhøjet blodtryk, opkastning, vægttab og forstoppelse.
The most common side effects with Cabometyx (seen in at least 1 in 4 people) are diarrhoea, tiredness, nausea (feeling sick), loss of appetite, palmar-plantar erythrodysaesthesia syndrome (hand- foot syndrome, which involves rash and numbness on the palms and soles), high blood pressure, vomiting, loss of weight and constipation.
De hyppigste bivirkninger ved Cancidas hos voksne (som kan forekomme hos op til 1 ud af 100 personer) er reduceret antal hæmoglobin eller røde blodlegemer, reduceret antal hvide blodlegemer, lavt kaliumniveau i blodet, hovedpine, betændelse i venerne, åndedrætsbesvær, kvalme, diarré, opkastning, forhøjet antal leverenzymer og bilirubin, (hvilket kan tyde på leverproblemer), udslæt, kløe, rødme på huden, kraftige svedeture, smerter i leddene, feber, kulderysten, kløe på injektionsstedet samt reduceret albuminniveau (et protein i blodet).
The most common side effects with Cancidas in adults (which may affect up to 1 in 100 people) are reduced levels of haemoglobin or red blood cells, reduced white blood cell count, low levels of potassium in the blood, headache, inflammation of the veins, shortness of breath, nausea, diarrhoea, vomiting, raised levels of liver enzymes and bilirubin (which may indicate liver problems), rash, itching, redness of skin, excessive sweating, joint pain, fever, chills, itching at injection site, and reduced levels of albumin, a protein in the blood.
De hyppigste bivirkninger ved Ceplene (som optræder hos mere end 1 ud af 10 patienter) er infektioner i de øvre luftveje (forkølelse), eosinofili (en stigning i antallet af eosinofiler - en type hvide blodlegemer), trombocytopeni (lavt antal blodplader), hovedpine, svimmelhed, dysgeusi (smagsforandring), takykardi (hurtig puls), rødmen, hypotension (lavt blodtryk), hoste, dyspnø (åndedrætsbesvær), kvalme, dyspepsi (fordøjelsesbesvær), diarré, udslæt, artralgi (ledsmerter), myalgi (muskelsmerter), pyreksi (feber), rigor (kulderystelser), træthed, influenzalignende symptomer, følelse af varme og reaktion på injektionsstedet, (rødme, kløe, smerter og betændelse).
The most common side effects with Ceplene (seen in more than 1 patient in 10) are upper respiratory tract infection (colds), eosinophilia (an increase in eosinophil levels, a type of white blood cell), thrombocytopenia (low blood platelet counts), headache, dizziness, dysgeusia (a bitter or unusual taste in the mouth), tachycardia (rapid heart beat), flushing (reddening), hypotension (low blood pressure), cough, dyspnoea (shortness of breath), nausea (feeling sick), dyspepsia (indigestion), diarrhoea, rash, arthralgia (pain in the joints), myalgia (muscle pain), pyrexia (fever), chills, fatigue (tiredness), flu-like symptoms, feeling hot and injection site reactions (redness, itching, pain and inflammation).
De hyppigste bivirkninger ved Cetrotide (som optræder hos mellem 1 og 10 patienter ud af 100) er overstimulation af æggestokkene i mild til moderat grad (hvilket kan forekomme som en bivirkning ved selve ovariestimulationsproceduren) og reaktioner på injektionsstedet, f.eks. rødme, kløe og hævelse.
The most common side effects with Cetrotide (seen in between 1 and 10 patients in 100) are mild to moderate overstimulation of the ovaries (which can occur as a side effect of the ovarian stimulation procedure itself) and reactions at the injection site, such as redness, swelling and itching.
De hyppigste bivirkninger ved Cimzia (som optræder hos mellem 1 og 10 patienter ud af 100) er bakterieinfektioner, herunder bylder (hulrum, som indeholder pus), virusinfektioner (herunder herpes, papillomavirus og influenza), eosinofile sygdomme (sygdomme i forbindelse med eosinofiler, som er en type hvide blodlegemer), leukopeni (et lavt antal hvide blodlegemer, herunder lave neutrofil- og lymfocytniveauer), kvalme, hovedpine (herunder migræne), føleforstyrrelser (såsom følelsesløshed, prikken og en brændende fornemmelse), hypertension (for højt blodtryk), hepatitis (leverbetændelse), herunder forhøjet leverenzymniveauer, udslæt, feber, smerter, asteni (svaghed), pruritus (kløe) og reaktioner på injektionsstedet.
The most common side effects with Cimzia (seen in between 1 and 10 patients in 100) are bacterial infections including abscesses (cavities containing pus), viral infections (including herpes, papillomavirus, and influenza), eosinophilic disorders (disorders of eosinophils, a type of white blood cell), leucopenia (low white blood cell counts including low levels of neutrophils and lymphocytes), nausea (feeling sick), headaches (including migraine), sensory abnormalities (such as numbness, tingling, burning sensation), hypertension (high blood pressure), hepatitis (liver inflammation) including increased levels of liver enzymes, rash, fever, pain, asthenia (weakness), pruritus (itching) and reactions at the injection site.
De hyppigste bivirkninger ved Clopidogrel/Acetylsalicylsyre Teva (som kan forekomme hos op til 1 ud af 10 personer) er blodansamling under huden (hæmatom), næseblødning (epistaxis), mave- tarmblødning (gastrointestinal blødning), mavesmerter (abdominalsmerter), halsbrand (dyspepsi), blå mærker og blødning, når der prikkes hul i huden.
The most common side effects with Clopidogrel/Acetylsalicylic acid Teva (which may affect up to 1 in 10 people) are haematoma (a collection of blood under the skin), epistaxis (nosebleeds), gastrointestinal haemorrhage (bleeding in the stomach or gut), diarrhoea, abdominal pain (stomach ache), dyspepsia (heartburn), bruising, and bleeding where the skin is punctured.
De hyppigste bivirkninger ved Coagadex (som kan forekomme hos op til 1 ud af 10 behandlede) er ømhed eller rødme på injektionsstedet, træthed og rygsmerter.
The most common side effects with Coagadex (which may affect up to 1 in 10 people) are pain or redness at the injection site, fatigue (tiredness), and back pain.
De hyppigste bivirkninger ved Corlentor (som optræder hos flere end 1 ud af 10 patienter) er lysfænomener eller »fosfener« (forbigående lysglimt i synsfeltet).
The most common side effect with Corlentor (seen in more than 1 patient in 10) is luminous phenomena or ‘phosphenes’ (a temporary brightness in the field of vision).
De hyppigste bivirkninger ved Crixivan (som optræder hos mere end 1 ud af 10 patienter) stigninger i middelcellevolumen (store røde blodceller), fald i neutrofiler (en form for hvide blodceller), hovedpine, svimmelhed, kvalme, opkastning, diarré, dyspepsi (halsbrand), isoleret asymptomatisk hyperbilirubinæmi (tilfælde af høje bilirubin-værdier, som ikke medfører nogen symptomer), stigning i antallet af leverenzymer (alanin og aspartat-aminotransferase), udslæt, tør hud, hæmaturi (blod i urinen), proteinuri (protein i urinen), krystaller i urinen, asteni (svækkelse) eller træthed, smagsforandring og mavesmerter.
The most common side effects with Crixivan (seen in more than 1 patient in 10) are increases in mean corpuscular volume (large red blood cells), decreases in neutrophils (a type of white blood cell), headache, dizziness, nausea (feeling sick), vomiting, diarrhoea, dyspepsia (heartburn), isolated asymptomatic hyperbilirubinaemia (instances of high blood bilirubin levels that do not cause any symptoms), increased levels of liver enzymes (alanine and aspartate transaminases), rash, dry skin, haematuria (blood in the urine), proteinuria (protein in the urine), crystalluria (crystals in the urine), asthenia (weakness) or fatigue (tiredness), taste perversion (an altered sense of taste) and abdominal pain (stomach ache).
De hyppigste bivirkninger ved Cubicin (som optræder hos mellem 1 og 10 patienter ud af 100) er svampeinfektioner (skimmel- og gærsvampe), urinvejsinfektioner, Candida-infektion (en svampeinfektion), anæmi (lavt antal røde blodceller), angst, søvnbesvær, svimmelhed, hovedpine, hypertension (forhøjet blodtryk), hypotension (for lavt blodtryk), gastrointestinale smerter og mavesmerter, kvalme, opkastning, forstoppelse, diarré, flatulens (luft i maven), oppustethed og udspilet mave, udslæt, kløe, smerte i lemmerne (arme eller ben), reaktioner på infusionsstedet, feber, kraftesløshed, unormale leverprøver og forhøjede blodkoncentrationer af et enzym kaldet CPK (en markør for muskelskader).
The most common side effects with Cubicin (seen in between 1 and 10 patients in 100) are infections caused by fungi (moulds and yeasts), urinary tract infections (infection of the structures that carry urine), Candida infection (a fungal infection), anaemia (low red blood cell counts), anxiety, insomnia (difficulty sleeping), dizziness, headache, hypertension (high blood pressure), hypotension (low blood pressure), gastrointestinal and abdominal pain (stomach ache), nausea (feeling sick), vomiting, constipation, diarrhoea, flatulence (gas), bloating and distension (feeling as if the tummy is full), rash, pruritus (itching), pain in the limbs (arms or legs), infusion site reactions, pyrexia (fever), asthenia (weakness), abnormal liver tests and raised levels in the blood of an enzyme called CPK (a marker of muscle damage).
De hyppigste bivirkninger ved Cyramza (som optræder hos mere end 1 ud af 10 personer) er træthed eller svaghed, lavt antal hvide blodlegemer (leukopeni), lavt antal hvide blodlegemer af en bestemt type (neutropeni), diarré, næseblødning (epistaxis) og inflammation af mundslimhinden (stomatitis).
The most common side effects with Cyramza (which may affect more than 1 in 10 people) include fatigue (tiredness) or weakness, leucopenia (low white blood cell counts), neutropenia (low counts of a particular type of white blood cell), diarrhoea, epistaxis (nosebleeds) and stomatitis (inflammation of the lining of the mouth).
De hyppigste bivirkninger ved Daxas (som optræder hos mellem 1 og 10 patienter ud af 100) er vægttab, nedsat appetit, søvnbesvær, hovedpine, diarré, kvalme og mavesmerter.
The most common side effects with Daxas (seen in between 1 and 10 patients in 100) are decreased weight, decreased appetite, insomnia (difficulty sleeping), headache, diarrhoea, nausea (feeling sick) and abdominal pain (stomach ache).
De hyppigste bivirkninger ved Defitelio (som kan forekomme hos op til en ud af 10 behandlede) er blødning, lavt blodtryk (hypotension) og problemer med blodets størkning (koagulopati).
The most common side effects with Defitelio (which may affect up to 1 in 10 people) are bleeding, hypotension (low blood pressure) and coagulopathy (problems with blood clotting).
De hyppigste bivirkninger ved Docetaxel Winthrop (som ses hos flere end 1 ud af 10 patienter) er neutropeni (lavt antal hvide blodlegemer), anæmi (for lavt antal røde blodlegemer), trombocytopeni (lavt antal blodplader), neutropeni med feber, perifer sensorisk neuropati (beskadigelse af nerverne i hænder og fødder), perifer motorisk neuropati (beskadigelse af nerverne, som giver problemer med at koordinere éns bevægelser), smagsforstyrrelser, åndenød (dyspnø), betændelse i mundslimhinden (stomatitis), diarré, kvalme, opkastning, hårtab, hudreaktioner, neglegener, myalgi (muskelsmerter), appetitløshed, infektioner, væskeansamlinger, kraftesløshed (asteni), smerter og overfølsomhed (allergiske reaktioner).
The most common side effects with Docetaxel Winthrop (seen in more than 1 patient in 10) are neutropenia (low levels of neutrophils), anaemia (low red blood cell counts), thrombocytopenia (low blood platelet counts), febrile neutropenia (neutropenia with fever), peripheral sensory neuropathy (nerve damage in the hands and feet), peripheral motor neuropathy (damage to the nerves causing difficulty co-ordinating movements), dysgeusia (taste disturbances), dyspnoea (difficulty breathing), stomatitis (inflammation of the lining of the mouth), diarrhoea, nausea (feeling sick), vomiting, alopecia (hair loss), skin reactions, nail disorders, myalgia (muscle pain), loss of appetite, infections, fluid retention, asthenia (weakness), pain and hypersensitivity (allergic reactions).
De hyppigste bivirkninger ved Ebymect (som kan optræde hos mere end 1 ud af 10 personer), er for lavt blodsukker (hypoglykæmi) (ved anvendelse sammen med insulin eller et sulfonylurinstof) og symptomer fra mave-tarmkanalen (gastrointestinale symptomer).
The most common side effects with Ebymect (which may affect more than 1 in 10 people) are hypoglycaemia (when used together with insulin or a sulphonylurea) and gastrointestinal symptoms (symptoms affecting the stomach and gut).
De hyppigste bivirkninger ved Edurant (som optræder hos flere end 1 ud af 10 patienter) er hovedpine, søvnløshed, svimmelhed, kvalme og forhøjede værdier af total kolesterol, low-density- lipoprotein (LDL), kolesterol, pankreasamylase (et enzym, der produceres i bugspytkirtlen og nedbryder stivelse til sukkerarter) og transaminaser (leverenzymer).
The most frequent side effects with Edurant (seen in more than 1 patient in 10) are headache, insomnia, dizziness, nausea (feeling sick), and increased levels of total cholesterol, low-density- lipoprotein (LDL) cholesterol, pancreatic amylase (an enzyme produced in the pancreas that breaks down starch into sugars) and transaminases (liver enzymes).
De hyppigste bivirkninger ved Eklira Genuair (som optræder hos mellem 1 og 10 patienter ud af 100) er sinusitis (bihulebetændelse), nasopharyngitis (betændelse i næse og hals), hovedpine, hoste og diarré.
The most common side effects with Eklira Genuair (seen in between 1 and 10 patients in 100) are sinusitis (inflammation of the sinuses), nasopharyngitis (inflammation of the nose and throat), headache, cough and diarrhoea.
De hyppigste bivirkninger ved Eliquis (som optræder hos mellem 1 og 10 ud af 100 patienter) er anæmi (lavt antal røde blodlegemer), hæmorrhagi (blødninger), hæmatom (blodansamling under huden), kontusioner (blå mærker) og kvalme, når Eliquis anvendes til forebyggelse af venøs tromboemboli.
The most frequent side effects with Eliquis (seen in between 1 and 10 patients in 100) are anaemia (low red blood cell counts), haemorrhage (bleeding), haematoma (a collection of blood under the skin), contusion (bruising) and nausea (feeling sick) when Eliquis is used for prevention of venous thromboembolism.
De hyppigste bivirkninger ved Empliciti (som optræder hos mere end 1 ud af 10 patienter) er infusionsreaktioner (med symptomer som f.eks. feber og kulderystelser), diarré, helvedesild (smertefulde, blæredannende hududslæt), ondt i halsen, hoste, lungebetændelse, forkølelse, lavt antal hvide blodlegemer og vægttab.
The most common side effects with Empliciti (which may affect more than 1 in 10 people) are infusion reactions (with symptoms such as fever and chills), diarrhoea, shingles (painful, blistering rash), sore throat, cough, pneumonia (lung infection), colds, low levels of white blood cells and weight loss.
De hyppigste bivirkninger ved Epoetin Alfa Hexal (som optræder hos flere end 1 ud af 10 patienter) er kvalme, diarré, opkastning, feber og hovedpine.
The most common side effects with Epoetin Alfa Hexal (seen in more than 1 patient in 10) are nausea (feeling sick), diarrhoea, vomiting, pyrexia (fever) and headache.
De hyppigste bivirkninger ved Eravac (som kan optræde hos mere end 1 ud af 10 dyr) er en kortvarig stigning i kropstemperaturen til lidt over 40 ºC, der kan opstå to-tre dage efter vaccinationen.
The most common side effect with Eravac (which may affect more than 1 in 10 rabbits) is a short-lived increase in body temperature to slightly above 40 ºC which may occur between two or three days following vaccination.
De hyppigste bivirkninger ved Exjade (som optræder hos flere end 1 ud af 10 patienter) er forhøjet kreatininindhold i blodet (et tegn på nyreproblemer).
The most common side effect with Exjade (seen in more than 1 patient in 10) is increased blood creatinine (a marker of kidney problems).
De hyppigste bivirkninger ved Extavia er influenzalignende symptomer (herunder feber, forkølelse, ledsmerter, utilpashed, sveden, hovedpine og muskelsmerter) og reaktioner på injektionsstedet.
The most frequent side effects with Extavia are flu-like symptoms (including fever, chills, arthralgia (joint pain), malaise (feeling unwell), sweating, headache and myalgia (muscle pain)) and reactions at the site of injection.
De hyppigste bivirkninger ved Eylea (som optræder hos mindst 1 ud af 20 patienter) er konjunktival blødning (blødning fra de små blodkar på øjets overflade på injektionsstedet), nedsat synsskarphed, smerter i øjnene, løsning af glaslegemet, grå stær (uklarhed af linsen), flydere i glaslegemet og forhøjet intraokulært tryk (forhøjet tryk i øjet).
The most common side effects (affecting at least 1 in 20 patients) reported with Eylea are conjunctival haemorrhage (bleeding from the small blood vessels on the surface of the eye at the site of injection), reduced vision, eye pain, vitreous detachment (detachment of the jelly-like substance inside the eye), cataract (clouding of the lens), vitreous floaters (small particles or spots in the vision) and increased intraocular pressure (increased pressure inside the eye).
De hyppigste bivirkninger ved Ferriprox (som optræder hos flere end 1 ud af 10 patienter) er rødlig- brun urin (der viser, at der bliver udskilt jern), kvalme, mavesmerter og opkastninger.
The most common side effects with Ferriprox (seen in more than 1 patient in 10) are reddish-brown urine (showing that iron is being eliminated), nausea (feeling sick), abdominal pain (stomach ache) and vomiting.
De hyppigste bivirkninger ved Firazyr (som optræder hos flere end 1 ud af 10 patienter) er rødme, hævelse, brændende fornemmelse, kløe og smerte på injektionsstedet.
The most common side effects with Firazyr (seen in more than 1 patient in 10) are erythema (redness), swelling,, burning, itching and pain at injection sites.
De hyppigste bivirkninger ved Foclivia (som optræder hos mellem 1 og 10 patienter ud af 100) er hovedpine, svedtendens, ledsmerter, muskelsmerter, reaktioner på injektionsstedet (rødme, hævelse, hårdhed, blå mærker og smerter), feber, utilpashed, træthed og kulderystelser.
The most common side effects with Foclivia (seen in between 1 and 10 people in 100) are headache, sweating, arthralgia (joint pain), myalgia (muscle pain), reactions at the site of the injection (redness, swelling, hardening, bruising, pain), fever, malaise (feeling unwell), fatigue (tiredness) and shivering.
De hyppigste bivirkninger ved Fosavance (som ses hos mellem 1 og 10 patienter ud af 100) er hovedpine, mavesmerter, dyspepsi (halsbrand), forstoppelse, diarré, flatulens (luft i maven), øsofagus-ulcus (sår i spiserøret), dysfagi (synkebesvær), udspilet mave, syreregurgitation (sure opstød) samt smerter i knogler, muskler og led.
The most common side effects with Fosavance (seen between 1 and 10 patients in 100) are headache, abdominal pain (stomach ache), dyspepsia (heartburn), constipation, diarrhoea, flatulence (gas), ulcers in the oesophagus, dysphagia (difficulty swallowing), abdominal distension (swollen tummy), acid regurgitation and musculoskeletal pain (pain in the muscles, bones and joints).
De hyppigste bivirkninger ved Gazyvaro (som kan forekomme hos op til 1 ud af 10 personer) er øvre luftvejsinfektioner (såsom hals- og næseinfektioner) hoste, diarré, forstoppelse, ledsmerter, feber, svækkelse, lavt antal hvide blodlegemer (neutropeni), lavt antal blodplader (trombocytopeni) og lavt antal røde blodlegemer (anæmi).
The most common side effects with Gazyvaro (which may affect more than 1 in 10 people) are upper respiratory infections (such as throad and nose infections), coughs, diarrhoea, constipation, joint pain, fever, weakness, neutropenia (low white blood cell counts), thrombocytopenia (low blood platelet counts) and anaemia (low red blood cell counts).
De hyppigste bivirkninger ved Gilenya (som optræder hos flere end 1 ud af 10 patienter) er influenzainfektioner, sinusitis (bihulebetændelse), hovedpine, hoste, diarré, rygsmerter og forhøjede leverenzymniveauer.
The most common side effects with Gilenya (seen in more than 1 patient in 10) are flu infections, sinusitis (inflammation of the sinuses), headache, cough, diarrhoea, back pain and raised liver enzyme levels.
De hyppigste bivirkninger ved Harvoni (som kan forekomme hos mere end 1 ud af 10 personer) er træthed og hovedpine.
The most common side effects with Harvoni (which may affect more than 1 in 10 people) are tiredness and headache.
De hyppigste bivirkninger ved Humira (som optræder hos flere end 1 ud af 10 patienter) var luftvejsinfektioner (infektion i lunger og luftveje), leucopeni (lavt antal hvide blodlegemer), anæmi (lavt antal røde blodlegemer), øgede lipidmængder i blodet (fedt), hovedpine, mavesmerter, kvalme og opkastning, udslæt, muskel- og ledsmerter, reaktioner på injektionsstedet (herunder rødme) og forhøjede leverenzymtal.
The most common side effects with Humira (seen in more than 1 patient in 10) were respiratory tract infections (infections of the lungs and airways), leucopenia (low white blood cell counts), anaemia (low red blood cell counts), increased blood levels of lipids (fats), headache, abdominal pain (stomach ache), nausea (feeling sick) and vomiting, rash, musculoskeletal pain (pain in the muscles and bones), injection-site reactions (including redness) and increased levels of liver enzymes.
De hyppigste bivirkninger ved Ilaris er infektioner, der generelt er milde til moderate, i de øvre luftveje (forkølelser).
The most common side effects with Ilaris are infections, generally mild to moderate, of the upper respiratory tract (colds).